日本における乾癬性関節炎患者の生物学的製剤治療継続性：診療報酬請求データベースを用いた後向きコホート研究

基本情報

NCT ID

NCT06600009

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

534

治験依頼者名

Novartis

概要

This study was a retrospective non-interventional cohort study with secondary use of data from the Medical Data Vision (MDV) hospital-based database. The study setting was defined as follows: * The inclusion period covered 01 February 2015 to 30 September 2020. * The study period covered 01 August 2014 to 30 September 2021 inclusive. * The index date was defined as the date of the first prescription of secukinumab or adalimumab within the inclusion period. * The pre-index period was defined as the 6-month period before the index date (exclusive). * Patients were followed until death, discontinuation of treatments of interest or end of the study period, whichever occurred first.

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)